Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no weight loss injection called Monzo. If you searched for a "Monzo weight loss injection", you were most likely thinking of Mounjaro, the UK-licensed tirzepatide injection used for weight management — the names sound similar enough to cause real confusion. Mounjaro is a prescription-only medicine made by Eli Lilly, and it is one of two injectable weight-loss treatments currently licensed in the UK for adults with obesity or a weight-related health condition. The other is Wegovy (semaglutide). Both require a clinical assessment before a prescriber can issue a prescription — there is no shortcut around that step, and nor should there be. This page explains what these medicines are, how they work in practice, and what the process of accessing them through a regulated UK pharmacy actually looks like.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The confusion between "Monzo" and "Mounjaro" is understandable. Phonetically they are close, and people searching for weight-loss injections often arrive at the name via word of mouth rather than reading a leaflet. Mounjaro is tirzepatide, a dual GIP and GLP-1 receptor agonist. Wegovy is semaglutide, a single GLP-1 agonist. Both are manufactured under strict pharmaceutical standards and supplied through the licensed UK supply chain.
Getting the name right matters beyond accuracy. Counterfeit weight-loss pens have been seized in the UK in significant volumes, the MHRA has warned publicly about fake pens sold via social media and unknown websites, some containing insulin rather than the stated medicine. Knowing the correct brand name, and where to verify the pharmacy supplying it, is part of staying safe. The only legal route to these medicines is a prescription issued after a genuine clinical assessment.
If someone told you about a "Monzo jab" or a Monzo injection for weight loss, they almost certainly meant Mounjaro. The rest of this page treats them as the same query.
Both medicines mimic gut hormones released after eating. That signals the brain to reduce hunger, slows the rate at which the stomach empties food into the small intestine, and (in the case of tirzepatide) also activates the GIP receptor, which plays a separate role in fat metabolism and insulin sensitivity. The result, for most people, is a meaningful and sustained reduction in appetite.
Injections are given once weekly, subcutaneously (just under the skin), into the abdomen, thigh or upper arm. You rotate the injection site each week to avoid tissue build-up. Each Mounjaro KwikPen contains four weekly doses; Wegovy comes as individual pre-filled pens. Treatment starts at a low starter dose (2.5mg for tirzepatide) which exists to settle your system rather than drive immediate weight loss; the prescriber increases the dose in steps over several months, depending on how you respond and tolerate it. For a fuller overview of the injection experience, including what to expect in the early weeks, the weight-loss injections guide covers that in detail.
The NHS tirzepatide page gives a patient-level summary of the medicine, including common side effects and what to do if you miss a dose, it is worth reading before you start.
UK licensing for both Mounjaro and Wegovy covers adults with a BMI of 30 or above, or 27 or above if you have at least one weight-related health condition) things like high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. BMI alone is not a guarantee of approval; a prescriber reviews the full picture, including your medical history, current medicines and any contraindications.
Neither medicine is licensed for people under 18, and both are not recommended during pregnancy, while breastfeeding, or if you are actively trying to conceive. Women taking oral contraceptives starting tirzepatide should add a non-oral method of contraception for the first four weeks of treatment and for four weeks after each dose increase, because the pill's absorption may be reduced during that period, a detail worth flagging to your GP or prescriber.
If you want to understand what the clinical criteria look like in practice and how they are assessed, the treatment overview page walks through the consultation process at nume. For context on what different treatment options involve, the weight-loss treatment comparison is a useful starting point.
A regulated online pharmacy will ask for photo ID, verify your weight (at nume this is done on a live video call) not self-reported), and have your answers reviewed by a named GPhC-registered Independent Prescriber on the same day. That prescriber reads your consultation, not software. If approved, the prescription is issued and your treatment is dispatched the same day for free next-working-day delivery via DPD, in plain packaging.
You can verify any online pharmacy on the GPhC register at pharmacyregulation.org, nume's premises registration number is 9012878. That link is publicly searchable and takes about thirty seconds to check. It is worth doing before you hand over payment details to any pharmacy you have not used before.
One practical note: if you are ordering a first prescription and want it dispatched the same day, placing your consultation before noon gives the prescriber time to review it and the pharmacy time to process and dispatch before the last DPD collection. After the school run is typically fine; mid-afternoon, less so on busy days.
Cost is a fair question too. Private injectable weight-loss treatment is not cheap, and prices vary between providers by dose and service level. The one-month injection cost guide explains the range honestly, including what headline prices often exclude. At nume, one transparent price covers the consultation, prescription, treatment and delivery, no subscription, no hidden charges. If you want to discuss your situation with a clinician before committing, our contact page has direct support options. For clinical team information, our lead prescriber's profile is there to read.
If you are taking ADHD medication alongside any weight-loss treatment, there are specific considerations worth discussing at consultation, the guide on injections and ADHD medication covers what is currently known.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.